Featured Research

from universities, journals, and other organizations

Risk markers for Alzheimer’s disease

Date:
October 23, 2010
Source:
Lund University
Summary:
Many proposed drugs for Alzheimer’s disease have been tested, but have not proved good enough. The reason could be because they have been tested on patients who have already developed dementia. At this point it could be too late to start medication, because the disease is now believed to begin decades before a patient displays clear symptoms. So how can we identify the patients who do not yet have Alzheimer’s, but who are at high risk of developing the disease?

Risk markers could play an important role in this. These are substances linked to Alzheimer's that are found in unusually high or unusually low quantities in patients who go on to develop the disease.

Associate Professor Oskar Hansson, linked to Lund University and Skεne University Hospital in Sweden, has identified two such risk markers. He has tested these on individuals who sought treatment at the hospital's memory clinic and who displayed 'mild cognitive impairment' -- poorer memory than normal for their age.

Of the 160 subjects tested, 33 per cent developed Alzheimer's disease within five years. Sixteen per cent developed other forms of dementia, while the remaining half stayed at the level of 'mild forgetfulness'. The risk markers made a quite clear distinction between those who would later suffer from Alzheimer's and those who were not at risk.

"The 'positive connection' was 71 per cent, which is not sufficient to definitely predict who will get the disease. The 'negative connection', on the other hand, was 94 per cent, which means that it is possible to predict who in all likelihood will not get the disease," says Oskar Hansson.

Those who do not have the risk markers are therefore not at high risk of developing Alzheimer's, despite having a poor memory. They can be given this reassuring news and do not have to return for regular Alzheimer's checks.

Individuals who do not have the risk markers can also be removed from all future clinical studies of new Alzheimer's drugs.

"The studies are simpler and more correct if they are done on the right patient group from the beginning, i.e. those who really are in the risk zone for Alzheimer's disease. It is also more ethical not to include patients who are not at risk. They have nothing to gain from the medication, but may have something to lose if the drug causes side-effects," says Oskar Hansson.

The biomarkers are extracted from spinal fluid through a needle inserted into the lower spine. This is not the same as a bone marrow test, which is a much more extensive and unpleasant procedure.

Incidence of Alzheimer's disease is increasing rapidly all over the world. In Sweden there are currently around 120 000 people with the disease, but the number is expected to increase in line with the aging population. Because patients require a lot of care, Alzheimer's and other forms of dementia are estimated to cost society as much as cardiovascular disease, cancer and stroke combined.


Story Source:

The above story is based on materials provided by Lund University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Joakim Hertze, Lennart Minthon, Henrik Zetterberg, Eugeen Vanmechelen, Kaj Blennow, Oskar Hansson. Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years. Journal of Alzheimer's Disease, 2010; 21 (4): 1119-1128 DOI: 10.3233/JAD-2010-100207

Cite This Page:

Lund University. "Risk markers for Alzheimer’s disease." ScienceDaily. ScienceDaily, 23 October 2010. <www.sciencedaily.com/releases/2010/10/101021090149.htm>.
Lund University. (2010, October 23). Risk markers for Alzheimer’s disease. ScienceDaily. Retrieved April 19, 2014 from www.sciencedaily.com/releases/2010/10/101021090149.htm
Lund University. "Risk markers for Alzheimer’s disease." ScienceDaily. www.sciencedaily.com/releases/2010/10/101021090149.htm (accessed April 19, 2014).

Share This



More Health & Medicine News

Saturday, April 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Nine-Month-Old Baby Can't Open His Mouth

Nine-Month-Old Baby Can't Open His Mouth

Newsy (Apr. 19, 2014) — Nine-month-old Wyatt Scott was born with a rare disorder called congenital trismus, which prevents him from opening his mouth. Video provided by Newsy
Powered by NewsLook.com
'Holy Grail' Of Weight Loss? New Find Could Be It

'Holy Grail' Of Weight Loss? New Find Could Be It

Newsy (Apr. 18, 2014) — In a potential breakthrough for future obesity treatments, scientists have used MRI scans to pinpoint brown fat in a living adult for the first time. Video provided by Newsy
Powered by NewsLook.com
Little Progress Made In Fighting Food Poisoning, CDC Says

Little Progress Made In Fighting Food Poisoning, CDC Says

Newsy (Apr. 18, 2014) — A new report shows rates of two foodborne infections increased in the U.S. in recent years, while salmonella actually dropped 9 percent. Video provided by Newsy
Powered by NewsLook.com
Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) — The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins